A detailed history of Vontobel Holding Ltd. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 40,000 shares of ACET stock, worth $38,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,000
Previous 40,000 -0.0%
Holding current value
$38,800
Previous $48,000 18.75%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.21 - $2.4 $15,730 - $31,200
13,000 Added 48.15%
40,000 $48,000
Q1 2024

May 10, 2024

BUY
$1.76 - $3.45 $47,520 - $93,150
27,000 New
27,000 $63,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $38.8M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.